Transient Pharma AB is a Swedish AB based in Lund, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2019, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas av Jensen, Johan Mikael i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva medicinsk forskning och utveckling, äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
In its most recent annual report (2025), Transient Pharma AB reported revenue of SEK 0. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 3.3m.
At the end of 2025, equity financed 98.2% of the balance sheet, and current assets covered short-term debt 55.5 times.
Frequently asked questions
What is the Org number of Transient Pharma AB?
Transient Pharma AB is registered with Bolagsverket / SCB under Org 5592007875.
Who is the CEO of Transient Pharma AB?
Maria Helene Lilian Hartman is the CEO of Transient Pharma AB, in role since 2020.
Who is the chairman of Transient Pharma AB?
Bo Ture David Benell chairs the board of Transient Pharma AB, in role since 2020.
Where is Transient Pharma AB headquartered?
Transient Pharma AB's registered address is Medicon Village Scheeletorget 1.
